Literature DB >> 8935804

5-HT modulation of auditory and visual sensorimotor gating: I. Effects of 5-HT releasers on sound and light prepulse inhibition in Wistar rats.

J H Kehne1, R A Padich, T C McCloskey, V L Taylor, C J Schmidt.   

Abstract

Increasing evidence suggests an important role for serotonin (5-HT) neurons in the etiology and treatment of schizophrenia. The prepulse inhibition paradigm is used as a model for sensorimotor gating processes that are disrupted in schizophrenia. The present study assessed the general role of 5-HT in modulating auditory and visual prepulse inhibition in Wistar rats. A general overactivation of central serotonerigic pathways was produced pharmacologically by four different agents which all shared the common property of releasing 5-HT, i.e., p-chloroamphetamine, 3,4-methylenedioxymethamphetamine, N-ethyl-3,4-methylenedioxymethamphetamine, or fenfluramine. Within each test session, both sound and light prepulses were used to obtain a cross-modal assessment of auditory and visual sensory gating processes. All four 5-HT releasing agents produced dose-related disruptions of auditory and visual prepulse inhibition, with p-chloroamphetamine being the most potent. The releasers depressed baseline to varying degrees. The alpha 2-adrenergic agonist clonidine decreased baseline startle without substantially disrupting prepulse inhibition, demonstrating that the two effects were dissociable. Using fenfluramine as the most selective 5-HT releaser, two approaches were used to demonstrate 5-HT mediation of its disruptive effect on prepulse inhibition. In the first approach, the selective 5-HT uptake blocker MDL 28,618A was used to prevent fenfluramine-induced 5-HT release. In the second approach, prior exposure to a neurotoxic dose of p-chloroamphetamine (10 mg/kg) was used to produce a substantial, sustained depletion of cortical 5-HT, presumably reflecting the loss of 5-HT terminals. Both approaches reduced the disruptive effect of fenfluramine on auditory and visual prepulse inhibition, thereby demonstrating 5-HT mediation of these effects. Neither manipulation significantly affected the depressant effect of fenfluramine on startle baseline, demonstrating that the baseline-reducing and prepulse inhibition-reducing effects of fenfluramine could be dissociated. MDL 28,618A alone did not affect prepulse inhibition or basal startle levels, demonstrating an important functional difference between pharmacologically induced 5-HT uptake blockade and 5-HT release. In summary, these data indicate that serotonergic overactivation can disrupt auditory and visual sensorimotor gating as measured using sound and light prepulse inhibition in rats. These data support a potential role of excessive 5-HT activity as a contributing factor to disrupted sensory gating processes seen in schizophrenia and possibly other neuropsychiatric disorders.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8935804     DOI: 10.1007/bf02245609

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  52 in total

1.  Subjective effects of 3,4-methylenedioxymethamphetamine in recreational users.

Authors:  S J Peroutka; H Newman; H Harris
Journal:  Neuropsychopharmacology       Date:  1988-12       Impact factor: 7.853

2.  Fenfluramine administered systemically or locally increases extracellular serotonin in the lateral hypothalamus as measured by microdialysis.

Authors:  D Schwartz; L Hernandez; B G Hoebel
Journal:  Brain Res       Date:  1989-03-20       Impact factor: 3.252

3.  Apomorphine disrupts the inhibition of acoustic startle induced by weak prepulses in rats.

Authors:  M Davis; R S Mansbach; N R Swerdlow; S Campeau; D L Braff; M A Geyer
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

Review 4.  Contribution of serotonin neurotoxins to understanding psychiatric disorders: the role of 5-HT2 receptors in schizophrenia and antipsychotic activity.

Authors:  C J Schmidt; J H Kehne; A A Carr; G M Fadayel; T M Humphreys; H J Kettler; T C McCloskey; R A Padich; V L Taylor; S M Sorensen
Journal:  Int Clin Psychopharmacol       Date:  1993-11       Impact factor: 1.659

5.  Concurrent determination of effects of p-chloroamphetamine on central extracellular 5-hydroxytryptamine concentration and behaviour.

Authors:  P H Hutson; G Curzon
Journal:  Br J Pharmacol       Date:  1989-04       Impact factor: 8.739

6.  Suppression of behavioral activity by norfenfluramine and related drugs in rats is not mediated by serotonin release.

Authors:  C W Callaway; L L Wing; D E Nichols; M A Geyer
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

7.  The substituted amphetamines 3,4-methylenedioxymethamphetamine, methamphetamine, p-chloroamphetamine and fenfluramine induce 5-hydroxytryptamine release via a common mechanism blocked by fluoxetine and cocaine.

Authors:  U V Berger; X F Gu; E C Azmitia
Journal:  Eur J Pharmacol       Date:  1992-05-14       Impact factor: 4.432

8.  Impaired startle prepulse inhibition and habituation in patients with schizotypal personality disorder.

Authors:  K S Cadenhead; M A Geyer; D L Braff
Journal:  Am J Psychiatry       Date:  1993-12       Impact factor: 18.112

9.  5-Hydroxytryptamine 1a receptor agonists block prepulse inhibition of acoustic startle reflex.

Authors:  G C Rigdon; J K Weatherspoon
Journal:  J Pharmacol Exp Ther       Date:  1992-11       Impact factor: 4.030

10.  Reversal of the acute effects of 3,4-methylenedioxymethamphetamine by 5-HT uptake inhibitors.

Authors:  C J Schmidt; V L Taylor
Journal:  Eur J Pharmacol       Date:  1990-05-31       Impact factor: 4.432

View more
  13 in total

1.  Restraint stress-induced reduction in prepulse inhibition in Brown Norway rats: role of the CRF2 receptor.

Authors:  Jane E Sutherland; Lisa H Conti
Journal:  Neuropharmacology       Date:  2010-12-23       Impact factor: 5.250

2.  5-HT modulation of auditory and visual sensorimotor gating: II. Effects of the 5-HT2A antagonist MDL 100,907 on disruption of sound and light prepulse inhibition produced by 5-HT agonists in Wistar rats.

Authors:  R A Padich; T C McCloskey; J H Kehne
Journal:  Psychopharmacology (Berl)       Date:  1996-03       Impact factor: 4.530

3.  Different serotonin receptor agonists have distinct effects on sound-evoked responses in inferior colliculus.

Authors:  Laura M Hurley
Journal:  J Neurophysiol       Date:  2006-07-26       Impact factor: 2.714

4.  Yohimbine disrupts prepulse inhibition in rats via action at 5-HT1A receptors, not alpha2-adrenoceptors.

Authors:  Susan B Powell; Javier Palomo; Barbara S Carasso; Vaishali P Bakshi; Mark A Geyer
Journal:  Psychopharmacology (Berl)       Date:  2005-02-18       Impact factor: 4.530

5.  Neurochemical changes in LPA1 receptor deficient mice--a putative model of schizophrenia.

Authors:  Claire Roberts; Panida Winter; Claire S Shilliam; Zoe A Hughes; Christopher Langmead; Peter R Maycox; Lee A Dawson
Journal:  Neurochem Res       Date:  2005-03       Impact factor: 3.996

6.  Chronic tryptophan deprivation attenuates gating deficits induced by 5-HT(1A), but not 5-HT₂ receptor activation.

Authors:  Roberto Stancampiano; Roberto Frau; Valentina Bini; Maria Collu; Manolo Carta; Fabio Fadda; Marco Bortolato
Journal:  Eur Neuropsychopharmacol       Date:  2012-11-06       Impact factor: 4.600

7.  The effect of corticotropin-releasing factor on prepulse inhibition is independent of serotonin in Brown Norway and Wistar-Kyoto rats.

Authors:  Jane E Sutherland; Michelle E Page; Lisa H Conti
Journal:  Pharmacol Biochem Behav       Date:  2008-01-16       Impact factor: 3.533

8.  Plasticity of the acoustic startle reflex in currently abstinent ecstasy (MDMA) users.

Authors:  Karsten Heekeren; Jörg Daumann; Mark A Geyer; Euphrosyne Gouzoulis-Mayfrank
Journal:  Psychopharmacology (Berl)       Date:  2004-01-14       Impact factor: 4.530

Review 9.  Pre-attentive processing and schizophrenia: animal studies.

Authors:  Bart A Ellenbroek
Journal:  Psychopharmacology (Berl)       Date:  2003-12-04       Impact factor: 4.530

10.  Behavioral and neurochemical characterization of mice deficient in the phosphodiesterase-4B (PDE4B) enzyme.

Authors:  Judith A Siuciak; Sheryl A McCarthy; Douglas S Chapin; Ashley N Martin
Journal:  Psychopharmacology (Berl)       Date:  2007-12-01       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.